At the CRO Forum Third Quarterly 2012 meeting the issue was raised that regulators do treat diversification effects differently, and have not a good reference to judge entities’ diversification benefits. Therefore it was decided that the CRO Forum would conduct a benchmark study assessing the CRO Forum member companies’ approaches taken to diversification.

The CRO Forum also decided that the assessment should include a (qualitative) assessment on fungibility of capital.

Moreover, the CRO Forum decided that the forum should identify the 4 key areas where discrepancies lie between the regulatory Solvency II view and companies’ internal view.